In summary, this study identified Pin1 as a novel positive regulator of two major downstream components (YAP and TAZ) of the Hippo signalling pathway and has shown that Pin-YAP/TAZ interaction increases the activity and stability of YAP and TAZ leading to the drug resistance and tumorigenecity of breast cancer cells. The gene discussed is DYNLL1; the disease is breast carcinoma.